Nonmedication, Alternative, and Complementary Treatments for Migraine
Overview
Authors
Affiliations
Purpose Of Review: The efficacy of some nonpharmacologic therapies appears to approach that of most drugs used for the prevention of migraine and tension-type headaches. These therapies often carry a very low risk of serious side effects and frequently are much less expensive than pharmacologic therapies. Considering this combination of efficacy, minimal side effects, and cost savings, medications should generally not be prescribed alone but rather in combination with nonpharmacologic therapies.
Recent Findings: In addition to the established nonpharmacologic therapies, such as biofeedback, relaxation training, butterbur, riboflavin, magnesium, and coenzyme Q10 (CoQ10) supplementation, recent data provide support for the use of aerobic exercise and acupuncture. Discovery of the high incidence of the C677T mutation of the methylenetetrahydrofolate reductase gene, MTHFR, and attendant elevation of homocysteine levels in patients with migraine with aura led to a trial of cyanocobalamin, folate, and pyridoxine in these patients. This trial showed that taking these three supplements resulted in a reduction of homocysteine levels and improvement of migraines.
Summary: Therapies proven (to various degrees) to be effective for migraine include aerobic exercise; biofeedback; other forms of relaxation training; cognitive therapies; acupuncture; and supplementation with magnesium, CoQ10, riboflavin, butterbur, feverfew, and cyanocobalamin with folate and pyridoxine.
Incorporating Therapeutic Education and Exercise in Migraine Management: A Biobehavioral Approach.
La Touche R, de Oliveira A, Paris-Alemany A, Reina-Varona A J Clin Med. 2024; 13(20).
PMID: 39458223 PMC: 11508379. DOI: 10.3390/jcm13206273.
Prescription of therapeutic exercise in migraine, an evidence-based clinical practice guideline.
La Touche R, Fierro-Marrero J, Sanchez-Ruiz I, Rodriguez de Rivera-Romero B, Cabrera-Lopez C, Lerma-Lara S J Headache Pain. 2023; 24(1):68.
PMID: 37286937 PMC: 10245624. DOI: 10.1186/s10194-023-01571-8.
Reina-Varona A, Rodriguez de Rivera-Romero B, Cabrera-Lopez C, Fierro-Marrero J, Sanchez-Ruiz I, La Touche R PeerJ. 2022; 10:e14150.
PMID: 36199286 PMC: 9528906. DOI: 10.7717/peerj.14150.
Ciancarelli I, Morone G, Tozzi Ciancarelli M, Paolucci S, Tonin P, Cerasa A Healthcare (Basel). 2022; 10(5).
PMID: 35628078 PMC: 9141187. DOI: 10.3390/healthcare10050941.
Coenzyme Q10 effects in neurological diseases.
Rauchova H Physiol Res. 2022; 70(Suppl4):S683-S714.
PMID: 35199552 PMC: 9054193. DOI: 10.33549/physiolres.934712.